Market Watch
A snapshot of what’s happening across the industry—a one-stop source for key developments across policy and regulatory changes, service and treatment innovations, technological advancements, industry recognition and accreditation, mergers and acquisitions, leadership shifts, and more.
Filter Options
-
By Categories
-
By Date Range
-
Sort Date By
-
Results Per Page
Clear Filters
-
Otsuka Pharmaceutical To Acquire Transcend Therapeutics
April 14, 2026Otsuka Pharmaceutical Co., Ltd., (Otsuka) has entered into an agreement to fully acquire Transcend Therapeutics, Inc., (Transcend) through its wholly owned subsidiary Otsuka America, Inc. The transaction, valued at up to $1.2 billion, is expected to close in the second… -
Centerstone To Open New Behavioral Health Clinic In Poplar Bluff, Missouri
April 14, 2026Centerstone is opening a new behavioral health clinic in Poplar Bluff, Missouri. The clinic will offer psychiatric evaluations, medication management, co-occurring disorder counseling, family and trauma therapy, care coordination, peer support, and group counseling and education. A ribbon-cutting ceremony is… -
Qualifacts Acquires MethodOne To Fully Integrate Medication-Assisted Treatment Into Its EHR Platforms For Substance Use Disorder Provider Organizations
April 14, 2026Qualifacts, a behavioral health technology company focused on electronic health record (EHR) and data solutions, has acquired MethodOne by Computalogic, a controlled-medication dispensing software designed for opioid treatment programs (OTPs) and substance use disorder (SUD) provider organizations. The deal brings… -
Sage Health Secures Investment To Expand As A Medicare-Focused, Full-Risk Primary Care Provider Organization
April 14, 2026Sage Health, a primary care provider organization serving Medicare-eligible seniors, has received a $50 million debt term loan from Trinity Capital Inc., an alternative asset manager. The financing brings Sage Health’s total capital raised to $170 million. The new capital… -
Click Therapeutics & Boehringer Ingelheim Secure Series D Funding To Advance Commercialization Of CT-155 Digital Therapeutic For Schizophrenia
April 14, 2026Boehringer Ingelheim and Click Therapeutics have reached an agreement under which Click Therapeutics will assume full commercial and regulatory responsibility for CT-155, an investigational prescription digital therapeutic being studied as a treatment for negative symptoms of schizophrenia in adults. Boehringer… -
Barnett Wellness Clinic Opens New Psychiatric Practice For All Ages In Texarkana, Arkansas
April 14, 2026Barnett Wellness Clinic opened a new psychiatric practice in Texarkana, Arkansas, founded by Grant Barnett, MNSc, APRN, PMHNP-BC. The clinic provides psychiatric services for children, adolescents, and adults. It operates on a concierge, direct-pay model, meaning it does not bill… -
WellStone Opens New Madison, Alabama Clinic For Adult Mental Health & Addiction Services
April 14, 2026WellStone has opened a clinic in Madison, Alabama to serve adults 19 and older seeking mental health and addiction treatment. Located at 9238 Madison Boulevard, Suite 900, the office provides individual therapy, group therapy, and intensive outpatient programs. Those who… -
TenderHeart Advances Value‑Based Durable Medical Equipment Models Aligned With CMS Priorities To Reduce Fraud, Waste & Abuse
April 14, 2026TenderHeart Health Outcomes has introduced a value-based payment model for durable medical equipment (DME), with an initial focus on incontinence supplies, which recently has drawn increased scrutiny from federal regulators. The Centers for Medicare & Medicaid Services (CMS) has publicly… -
PointClickCare Launches The Study Buddy Research Platform To Deliver Instant, Grant Submission-Ready Evidence From Its Long-Term Care Data
April 14, 2026PointClickCare has launched Study Buddy, an artificial intelligence (AI)-powered research platform designed to support academic and clinical research using PointClicCare’s real-world data from long-term care (LTC) settings. The platform draws on PointClickCare’s longitudinal LTC dataset, which is de-identified in accordance… -
Study Finds Adherence To Extended-Release Buprenorphine Associated With Lower Health Care Costs In Insured Adults With Opioid Use Disorder
April 14, 2026A new study published in Frontiers in Public Health examined the relationship between adherence to extended-release buprenorphine (BUP-XR) and health care utilization and costs among insured adults with opioid use disorder (OUD). The retrospective analysis used U.S. commercial and Medicare…
3048 Results | Page 1 of 305